Use of the uNGAL biomarker in the early diagnostics of cardiac-surgery-associated acute kidney injury in neonates
DOI:
https://doi.org/10.37800/RM.2.2023.82-88%20Keywords:
congenital heart defects, newborns, acute kidney injury (AKI), biomarker, uNGALAbstract
Relevance: Acute kidney injury (AKI) in children after cardiac surgery on the open heart is called Cardiac surgery-associated (CSA)-AKI. The frequency of CSA-AKI in newborns is high, about 45-64%. In this connection, the issue of early diagnosis of AKI and the search and justification of new AKI biomarkers remains acute. One of the promising biomarkers among them is uNGAL (urinary NGAL).
The study aimed to establish the frequency of CSA-AKI and study the diagnostic value of the new biomarker uNGAL in newborns with CHD in the perioperative period.
Materials and Methods: A two-center prospective study of 35 newborns with a congenital heart defect after open surgery using a pulmonary bypass was conducted from 2019 to 2021. The CSA-AKI frequency was established using the modified KDIGO Neonatal AKI (mKDIGO) international neonatal сlassification criteria, according to which the patients were divided into two groups: “AKI(+)” and “AKI(-).”
Results: The incidence of CSA AKI was 45.7% (n=16). The AKI frequency by the mKDIGO classification stage was as follows: Stage 1 – 8 (50%) children, Stage 2 – 4 (25%), and Stage 3 – 4 (25%). Before surgery, the mean uNGAL value was 173.5 ng/mL (p<0.001) in the AKI(+) group compared to 30.1 ng/mL in the AKI(-) group. In the first 24 hours after surgery, the urine uNGAL in neonates with AKI increased to an average of 320.7 ng/mL (p<0.001), compared with patients without AKI who had 31.8 ng/mL. In the AKI(+) group, the uNGAL level slightly decreased to 263.6 ng/mL on Day 3 after surgery and increased again on Day 7 to 418.6 ng/mL, which was almost 1.5 times higher than the Day 3 level. The difference was statistically significant (p<0.001). ROC analysis in the AKI(+) group showed that the most significant sensitivity was registered before surgery (93.3%) and on Day 1 after surgery (92.9%).
The highest specificity of uNGAL in the AKI(+) group was registered before surgery (90%) and on Day 3 (89.5%) after surgery.
Conclusion: For the first time in Kazakhstan, new data on the incidence of CSA-AKI in newborns were obtained, and the diagnostic value of a new AKI biomarker in the early diagnosis of CCA-AKI with high sensitivity and specificity was studied.
References
Sadykova A., Boranbayeva R., Berdiyarova G., Zhubanysheva K., Anohina S., Kulimbet M., Ospanova D., Tanabayeva S., Fakhradiyev I. Epidemiology of congenital malformations in Kazakhstan // Arch. Balk. Med. Union. – 2021. – Vol. 56(3). – P. 298-308. https://doi.org/10.31688/ABMU.2021.56.3.03
Yuan S.M. Acute kidney injury after pediatric cardiac surgery // Pediatr. Neonatol. – 2019. Vol. 60(1). – P. 3-11. https://doi.org/10.1016/j.pedneo.2018.03.007
Ueno K., Seki S., Shiokawa N., Matsuba T., Miyazono A., Hazeki D., Imoto Y., Kawano Y. Validation of acute kidney injury according to the modified KDIGO criteria in infants after cardiac surgery for congenital heart disease // Nephrology (Carlton). – 2019. – Vol. 24(3). – P. 294-300. https://doi.org/10.1111/nep.13240
Gist K.M., Blinder J.J., Bailly D., Borasino S., Askenazi D.J., Cooper D.S., Krawczeski C.D., Gaies M., Morales D.L.S., Hock K.M., Alten J. Neonatal and Paediatric Heart and Renal Outcomes Network: design of a multi-centre retrospective cohort study // Cardiol. Young. –2019. – Vol. 29(4). – P. 511-518. https://doi.org/10.1017/S1047951119000210
Alcaraz A.J., Gil-Ruiz M.A., Castillo A. Postoperative neutrophil Gelatinase–Associated lipocalin predicts acute kidney injury after pediatric cardiac surgery // Pediatr. Crit. Care. Med. – 2014. – Vol. 15. – P. 121-130. https://doi.org/10.1097/PCC.0000000000000034
Schroeder L.W., Buckley J.R., Stroud R.E., Martin R.H., Nadeau E.K., Barrs R., Graham E.M. Plasma Neutrophil Gelatinase-Associated Lipocalin Is Associated With Acute Kidney Injury and Clinical Outcomes in Neonates Undergoing Cardiopulmonary Bypass // Pediatr. Crit. Care Med. – 2019. – Vol. 20(10). – P. 957-962. https://doi.org/10.1097/PCC.0000000000002035
Adams P.S., Vargas D., Baust T., Saenz L., Koh W., Blasiole B., Callahan P.M., Phadke A.S., Nguyen K.N., Domnina Y., Sharma M., Kellum J.A., Sanchez-de-Toledo J. Associations of Perioperative Renal Oximetry Via Near-Infrared Spectroscopy, Urinary Biomarkers, and Postoperative Acute Kidney Injury in Infants After Congenital Heart Surgery: Should Creatinine Continue to Be the Gold Standard? // Pediatr. Crit. Care. Med. –2019. – Vol. 20(1). – P. 27-37. https://doi.org/10.1097/PCC.0000000000001767
Brennan K.G., Parravicini E., Lorenz J.M., Bateman D.A. Patterns of Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury in Neonates Receiving Cardiopulmonary Bypass // Children (Basel). – 2020. – Vol. 7(9). – P. 132. https://doi.org/10.3390/children7090132
Jetton J.G., Boohaker L.J., Sethi S.K., Wazir S., Rohatgi S., Soranno D.E., Chishti A.S., Woroniecki R., Mammen C., Swanson J.R., Sridhar S., Wong C.S., Kupferman J.C., Griffin R.L., Askenazi D.J., on behalf of the Neonatal Kidney Collaborative (NKC). Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study // Lancet Child Adol. Health. – 2017. – Vol. 1(3). – P. 184-194. https://doi.org/10.1016/S2352-4642(17)30069-X
Ramírez M., Chakravarti S., Busovsky-McNeal M., McKinstry J., Al-Qaqaa Y., Sahulee R., Kumar T.K.S.., Li X, Goldberg J.D., Gefen A.M., Malaga-Dieguez L. Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital Heart Surgery // J. Pediatr. Intens. Care. – 2021. – Vol. 11(2). – P. 153-158. https://doi.org/10.1055/s-0041-1740359
Webb T.N. Detection of Acute Kidney Injury in Neonates after Cardiopulmonary Bypass // Nephron. – 2022. – Vol. 146(3). – P. 282-285. https://doi.org/10.1159/000522316
Alten J.A., Cooper D.S., Blinder J.J., Selewski D.T., Tabbutt S., Sasaki J., Gaies MG, Bertrandt RA, Smith AH, Reichle G, Gist KM, Banerjee M, Zhang W, Hock KM, Borasino S; Neonatal and Pediatric Heart and Renal Outcomes Network (NEPHRON) Investigators. Epidemiology of Acute Kidney Injury After Neonatal Cardiac Surgery: A Report From the Multicenter Neonatal and Pediatric Heart and Renal Outcomes Network // Crit Care Med. –2021. – Vol. 49(10). – P. e941-e951. https://doi.org/10.1097/CCM.0000000000005165
Kari J.A., Shalaby M.A., Sofyani K., Sanad A.S., Ossra A.F., Halabi R.S., Aljuhani M.H., Toffaha W.M., Moria F.A., Sabry S., Ahmed H.A., Alhasan K.A., Sharief S., Safdar O. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU // World J. Pediatr. – 2018. – Vol. 14(2). – P. 134-142. https://doi.org/10.1007/s12519-017-0110-x
Shi S., Fan J., Shu Q. Early prediction of acute kidney injury in neonates with cardiac surgery // World J. Pediatr. Surg. – 2020. – Vol. 3(2). – Art. no. e000107. http://dx.doi.org/10.1136/wjps-2019-000107
Садыкова А.Ж. Современное состояние проблемы ранней диагностики острого почечного повреждения у новорожденных // Педиатрия и детская хирургия. – 2018. –№4(94). – С. 48-53 [Sadykova A.Zh. Sovremennoe sostoyanie problemy rannej diagnostiki ostrogo pochechnogo povrezhdeniya u novorozhdennyx // Pediatriya i detskaya xirurgiya. – 2018. –№4(94). – S. 48-53 (in Russ.)]. http://elibrary.ru/item.asp?id=41602776
Greenberg J.H., Parikh C.R. Biomarkers for Diagnosis and Prognosis of AKI in Children: One Size Does Not Fit All // CJASN. – 2017. – Vol. 12(9). – P. 1551-1557. https://doi.org/10.2215/CJN.12851216
Садыкова А.Ж., Боранбаева Р.З., Сарсенбаева Г.И., Сепбаева А.Д., Жовнир В.А., Бердиярова Г.С., Чингаева Г.Н. Частота и факторы риска острого повреждения почек в неонатальной кардиохирургии // Фармация Казахстана. – 2022. - №1(240).- С. 28-35 [Sadykova A.Zh., Boranbaeva R.Z., Sarsenbaeva G.I., Sepbaeva A.D., Zhovnir V.A., Berdiyarova G.S., Chingaeva G.N. Chastota i faktory riska ostrogo povrezhdeniya pochek v neonatal'noj kardioxirurgii // Farmaciya Kazaxstana. – 2022. - №1(240).- S. 28-35 (in Russ.)]. https://elibrary.ru/item.asp?id=48458047
Downloads
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.